Tag: Clinical Trial
StemCyte Expands Support of World Renowned Spinal Cord Injury Researcher Through Agreement with Rutgers...
StemCyte, Rutgers Sign Research, Licensing Agreement for Novel Human Umbilical Cord Blood Treatment for Spinal Cord Injury Being Developed by Wise Young, M.D., Ph.D.
NEW...
9 Out Of 10 Patients Walk Again In Some Form With Device, Therapy
On average, it happens every hour of every day - someone suffers a spinal cord injury** that can leave them paralyzed for life. An...
New hope on spinal injury
SCIENTISTS are on the brink of a major potential breakthrough in the repair of spinal cord injuries.
Action Medical Research, a national charity, has said...
Progress after Adult Stem Cell Therapy Offers New Hope to Iowa Spinal Cord Injury...
Rich Welsh, a 28 year-old insurance agent from Klemme, Iowa who suffered a spinal cord injury after an automobile accident in 1999, is now...
Medical Marvel
Doctors can't explain why Pat Rummerfield is able to run marathons and race cars. Even so, there are scores of quadriplegics who long to...
Cethrin for treatment of acute spinal cord injury
Alseres pharmaceuticals concludes enrollment in the Cethrin phase I/IIa clinical trial in acute spinal cord injury
Alseres Pharmaceuticals, Inc., announced that it has concluded enrollment...
Researchers ask: Is China the sleeping giant of biotech?
PARIS (AFP) — China's biotech sector accounts for just a sliver of its pharmaceutical industry and operates under the cloud of a massive review...
Synthetic Blood Announces Oxycyte Development Strategy
COSTA MESA, Calif.--(BUSINESS WIRE)--Synthetic Blood International, Inc. (OTCBB: SYBD - News) today announced its near-term development strategy for Oxycyteâ„¢. The Company finalized its Phase...
Urologist Uses Botox to Treat Debilitating Condition
Newswise — Eight years ago, Lynette Kunz suffered a severe spinal cord injury that left her a quadriplegic and sufferer of involuntary bladder contractions....
Stem cells target paralysis
Neuralstem Inc., the tiny Rockville biotech whose human stem cells have helped paralyzed rats walk again, is poised to launch its first trials on...



